Home » Featured » Page 35
Featured
Nearly $583 million has been dispatched to 1,385 Health Resources and Services Administration (HRSA)-funded health centers throughout the United States and its territories to bolster COVID-19 testing, the U.S. Department of Health and Human Services (HHS) announced last week.
“Widespread... Read More »
Researchers at Johns Hopkins Bloomberg School of Public Health expect to shortly begin two trials of convalescent plasma – plasma taken from recovered COVID-19 patients – next week, with an eye on reducing hospital strain and helping both high-risk populations and those getting sick at... Read More »
U.S. Rep. Brian Higgins (D-NY) will introduce a bill that would create a new agency within the Department of Health and Human Services, the National Medical Command (NMC).
This new independent agency would be charged with preparing for, monitoring, and responding to pandemics. Further, it would... Read More »
The first American participants in the Phase 1/2 clinical trial of the BNT162 vaccine program, created by Pfizer Inc. and BioNTech SE, have been dosed as the companies ramp up manufacturing capabilities to meet 2020/2021 capacity needs.
That vaccine is meant to treat COVID-19, the disease that... Read More »
Following the results of two clinical trials for the experimental antiviral drug remdesivir, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) last week, opening it to use as a treatment for those with severe cases of COVID-19.
“Based on evaluation of the... Read More »
A group of 14 Democratic U.S. senators is calling on Congress to include $8 billion in new funding for contact tracing to fight the COVID-19 virus.
Contact tracing is the process of tracking infected people to find out who they have been in contact with to stop the spread of the virus.... Read More »
Senate Democrats introduced legislation that lays out a framework for a coordinated federal response to the COVID-19 pandemic.
The Medical Supply Transparency and Delivery Act requires the president to utilize all available authorities under the Defense Production Act to mobilize a federal... Read More »
The Phase 3 SIMPLE trial of Gilead Sciences Inc’s antiviral drug remdesivir has reached its primary endpoint, supplying positive data that COVID-19 patients administered the drug early fared better than those treated later.
From 397 patients, the study revealed that 62 percent of patients... Read More »
Criticizing President Donald Trump’s unilateral decision to end funding for the World Health Organization (WHO) as reckless, Democratic members of the House Committee on Foreign Affairs called on the president to restore funding and to stop putting COVID-19 blame on the organization.
Chairman... Read More »
U.S. Rep. Frank Lucas (R-OK) introduced a bill in the House that authorizes additional scientific research to fight the novel coronavirus and other infectious diseases.
The legislation -- the Computing Opportunities to Vanquish Infectious Diseases Research Act of 2020 (the COVID Research Act)... Read More »
The Department of Health and Human Services (HHS) announced last week that the Centers for Disease Control and Prevention (CDC) is awarding $631 million to 64 jurisdictions in support of the COVID-19 response.
“This new funding secured from Congress by President Trump will help public health... Read More »
From flooding to wildfires to the novel coronavirus, health emergencies have dominated and redefined public life in the last year. Experts say that keeping Americans safe from these disasters requires a well-funded public health system focused on three key areas: prevention, preparedness, and... Read More »
Under legislation introduced by a collection of nine Democratic senators this week, AmeriCorps would take on more Americans and offer greater compensation, as part of a three-year response and recovery period linked to the COVID-19 pandemic.
The Pandemic Response and Opportunity Through National... Read More »
The spread of coronavirus in the United States has unveiled various levels of inequalities in society, including between major cities with more robust hospital systems and rural communities with less access to resources.
The COVID-19: A Frontline Guide for Local Decision-Makers, a global... Read More »
Despite high scores on the Global Health Security (GHS) index, the United States has fundamentally weak health security, the Nuclear Threat Initiative (NTI) warns, and its struggle with COVID-19 has emphasized its inadequate ability to deal with a pandemic.
COVID-19 has spawned more than... Read More »
U.S. Rep. Frank Pallone (D-NJ) is calling on the Trump Administration to develop a comprehensive COVID-19 testing strategy as part of its efforts to reopen the economy.
Pallone, chair of the House Energy and Commerce Committee, is concerned that the Trump Administration appears to be abandoning... Read More »
Legislation introduced in the U.S. House seeks to ensure greater accountability in the distribution of personal protective equipment (PPE) and other emergency resources under the Defense Protection Act and Stafford Act.
Specifically, the bill -- the Emergency Supply Chain Transparency Act --... Read More »
In a teleconference between experts from the Immunization Action Coalition, FasterCures and the U.S. Food and Drug Administration (FDA) on Friday, one thing was made abundantly clear: the world needs the best possible vaccines to combat COVID-19 as quickly as possible.
In the opinion of Dr.... Read More »
Congressional legislators on Friday introduced two bipartisan bills in the U.S. House of Representatives to bolster the Strategic National Stockpile (SNS), the nation’s repository of antibiotics, vaccines and other critical medical supplies that has been strained by the current coronavirus... Read More »
Citing an increased need for medical staff to handle the surge in confirmed COVID-19 cases, Sen. Bob Menendez (D-NJ) and Rep. Albio Sires (D-N.J.) are encouraging the waiving of restrictions on doctors with employment-based visas.
The legislators said the restrictions prevent the doctors from... Read More »
The push for convalescent plasma and hyperimmune globulin immunotherapies to use against COVID-19 continues at the federal level, with the U.S. Department of Health and Human Services (HHS) touting collaboration with non-governmental entities to see it done.
These immunotherapies could... Read More »
President Donald Trump’s pledge to halt funding to the World Health Organization (WHO) while the White House reviews its handling of the COVID-19 outbreak has drawn immediate criticism from the health community.
“We must all be allies against this threat; this is not the time to stand... Read More »
The United Nations Foundation is awarding $10 million to CEPI, the Coalition for Epidemic Preparedness, to develop a COVID-19 vaccine.
This award is through the UN Foundation’s COVID-19 Solidarity Response Fund for the World Health Organization (WHO). The fund was set up to raise funds for... Read More »
A group of Democratic U.S. Senators will introduce a bill to establish a commission to examine the country’s response to the coronavirus pandemic.
The commission would be charged with reviewing the government’s coronavirus response and make recommendations on how it can be improved. The bill... Read More »
The malaria and arthritis drug much-touted by President Donald Trump, hydroxychloroquine, is getting its chance under the microscope now, with the beginning of a clinical trial by the National Institutes of Health to determine its potential as a COVID-19 therapy.
Testers hope the drug could have... Read More »
Every day during the COVID-19 pandemic seems to bring word of a new potential vaccine, treatment or diagnostic being considered or pursued, but the vaccine R&D team at the Coalition for Epidemic Preparedness Innovations (CEPI) has made them easier to track.
In a new analysis published in Nature... Read More »
Teaming up with the United States government, health technology provider Royal Philips has agreed to double the production of hospital ventilators at its U.S. manufacturing sites by May and push for a four-fold increase by the third quarter.
These supplies would then be usable in both the U.S.... Read More »
The U.S. Food and Drug Administration accepted Inovio Pharmaceuticals investigational new drug (IND) application for its vaccine candidate designed to prevent COVID-19 infection.
This action by the FDA paves the way for Phase 1 clinical testing of this vaccine candidate, INO-4800, in healthy... Read More »
Hydroxychloroquine is flooding the Strategic National Stockpile this week as a potential treatment for COVID-19, thanks to a 30 million dose donation from Sandoz and another 1 million gifted by Bayer Pharmaceuticals.
Both hydroxychloroquine sulfate and chloroquine phosphate were given U.S. Food... Read More »
A bill recently introduced in the U.S. House of Representatives seeks to establish a National Commission on United States Preparedness for National Emergencies.
The Made in America Emergency Preparedness Act authorizes the creation of a National Commission on United States Preparedness for... Read More »
The federal government has seized hundreds of thousands of personal protective equipment (PPE) from price gougers with the intent of redistributing them to frontline workers working amid the COVID-19 crisis in New York and New Jersey.
The items -- which included around 192,000 N95 respirator... Read More »
Sarah Lofgren’s voice had a tinge of excitement when she explained why the bright green dots on one scientific slide disappeared on the next. The co-investigator at the University of Minnesota Division of Infectious Disease and International Medicine showed how SARS, or severe acute respiratory... Read More »
U.S. Sen. Gary Peters (D-MI) is urging the Trump Administration to address the nationwide shortage of personal protective equipment (PPE) for healthcare workers and emergency responders.
In his home state, Peters cited the travails of the Detroit Police Department, which has had to quarantine... Read More »
According to a journal report published by members of the Coalition for Epidemic Preparedness Innovation (CEPI) this week, SARS-CoV-2 -- the virus which causes COVID-19 -- uncovers the advances and ongoing stumbling blocks in vaccine development.
Other outbreaks and epidemics have helped lead... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is speeding up timelines for clinical trials of COVID-19 vaccine candidates produced by Janssen Research & Development and Moderna.
“Vaccines are essential to saving lives,” BARDA Director Rick Bright said. “Delivering a... Read More »
